A groundbreaking study uncovers how artificial hearts enable muscle regeneration, potentially paving the way for innovative heart failure treatments...
Vous n'êtes pas connecté
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
A groundbreaking study uncovers how artificial hearts enable muscle regeneration, potentially paving the way for innovative heart failure treatments...
A groundbreaking study uncovers how artificial hearts enable muscle regeneration, potentially paving the way for innovative heart failure treatments...
Beta-hydroxybutyrate (BHB), a ketogenic diet metabolite, enhances CAR T cell activation, offering a cost-effective boost for cancer immunotherapy.
Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.
Remains of cells once lived in by the Ukrainian Orthodox saint, Paisius Velichkovsky (also spelled, Paisii Velichkovsky), were recently discovered in...
Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo
Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo
Researchers reveal insulin resistance may be driven by insulin degradation during transit in the bloodstream, challenging the belief that cell defects...